Amrad Corporation Limited (“Amrad” and the “Company”) (ASX:AML) is a drug discovery and development biotechnology company based in Melbourne, Australia. Amrad’s core business is discovering and commercialising drugs based on molecules the body normally uses to regulate its various internal processes. These molecules, known as biologicals or cytokines, are involved in the regulation of a broad range of bodily functions and hence may have applications in a variety of diseases.
Amrad’s current R&D portfolio includes projects in the therapeutic areas of cancer, inflammation, asthma, rheumatoid arthritis and cardiovascular disease.
